A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

被引：179

作者：

Popat, Rakesh ^{[1
,2
]}

Plesner, Torben ^{[3
]}

Davies, Faith ^{[4
]}

Cook, Gordon ^{[5
]}

Cook, Mark ^{[6
]}

Elliott, Peter ^{[7
]}

Jacobson, Eric ^{[7
]}

Gumbleton, Todd ^{[1
]}

Oakervee, Heather ^{[1
]}

Cavenagh, Jamie ^{[1
]}

机构：

[1] St Bartholomews Hosp, London, England

[2] UCL Canc Inst, London, England

[3] Vejle Hosp, Vejile, Denmark

[4] Royal Marsden Hosp, Surrey, England

[5] St James Hosp, Leeds LS9 7TF, W Yorkshire, England

[6] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England

[7] GSK Co, Sirtris, Cambridge, MA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 160卷 / 05期

关键词：

myeloma; clinical trials; renal medicine; APOPTOSIS; PROTEINS;

D O I：

10.1111/bjh.12154

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：714 / 717

页数：4

共 9 条

[1] Therapeutic potential of resveratrol:: the in vivo evidence [J].

Baur, Joseph A. ;

Sinclair, David A. .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506

[2] Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells [J].

Bhardwaj, Anjana ;

Sethi, Gautam ;

Vadhan-Raj, Saroj ;

Bueso-Ramos, Carlos ;

Takada, Yasunari ;

Gaur, Upasna ;

Nair, Asha S. ;

Shishodia, Shishir ;

Aggarwal, Bharat B. .

BLOOD, 2007, 109 (06) :2293-2302

[3] Guidelines for the diagnosis and management of multiple myeloma 2011 [J].

Bird, Jennifer M. ;

Owen, Roger G. ;

D'Sa, Shirley ;

Snowden, John A. ;

Pratt, Guy ;

Ashcroft, John ;

Yong, Kwee ;

Cook, Gordon ;

Feyler, Sylvia ;

Davies, Faith ;

Morgan, Gareth ;

Cavenagh, Jamie ;

Low, Eric ;

Behrens, Judith .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) :32-75

[4]

Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x

[5] Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases-Safety, Pharmacokinetics, and Pharmacodynamics [J].

Howells, Lynne M. ;

Berry, D. P. ;

Elliott, P. J. ;

Jacobson, E. W. ;

Hoffmann, E. ;

Hegarty, B. ;

Brown, K. ;

Steward, W. P. ;

Gescher, A. J. .

CANCER PREVENTION RESEARCH, 2011, 4 (09) :1419-1425

[6] Cancer chemopreventive activity of resveratrol, a natural product derived from grapes [J].

Jang, MS ;

Cai, EN ;

Udeani, GO ;

Slowing, KV ;

Thomas, CF ;

Beecher, CWW ;

Fong, HHS ;

Farnsworth, NR ;

Kinghorn, AD ;

Mehta, RG ;

Moon, RC ;

Pezzuto, JM .

SCIENCE, 1997, 275 (5297) :218-220

[7]

Jazirehi AR, 2004, MOL CANCER THER, V3, P71

[8] Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins [J].

Michishita, E ;

Park, JY ;

Burneskis, JM ;

Barrett, JC ;

Horikawa, I .

MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (10) :4623-4635

[9]

Sirtris Pharmaceuticals Inc, 2009, SRT501 INV BROCH ONC

← 1 →